scholarly journals CANCER OF TRACHEA, BRONCHI AND LUNG IN THE FAR EASTERN FEDERAL DISTRICT

2019 ◽  
Vol 1 (71) ◽  
pp. 71-79
Author(s):  
Виктор Гордиенко ◽  
Viktor Gordienko ◽  
А. Вахненко ◽  
A. Vahnenko ◽  
Д. Екония ◽  
...  
Keyword(s):  
Medical Care ◽  
Cancer Patients ◽  
Federal District ◽  
Morbidity And Mortality ◽  
Malignant Neoplasms ◽  
Oncology Patients ◽  
Female Population ◽  
Annual Increase ◽  
Number Of Patients ◽  
Far Eastern

The first two decades of the XXI century in the Far Eastern Federal District continue to be characterized by a constantly decreasing level of the population living on its territory with an annual increase in the number of patients with cancer pathology, which makes a negative contribution to the already negative demographic situation in the region. The purpose of this study was to make a scientific assessment of the main morbidity and mortality rates of the population from malignant tumors of the trachea, bronchi and lung in the Far Eastern Federal District over the past ten years (2008-2017). In the course of the work, morbidity and mortality indicators, reporting forms of statistical records of cancer patients and regulatory documents of higher organizations, information on ten-year observations of the dynamics of changes in the numerical values of indicators of the studied pathology were used. The main indicators of medical care for oncology patients in the Far Eastern Federal District are shown, and it was found out that 3180 new cases of tracheal, bronchial and lung malignant neoplasms were registered in 2017, which is 30.9% more than ten years ago (in 2008 there were 2429 cases). The maximum number of cases was in the age group of 50-69 years. The number of patients with stages I-II (29.4%) of the cancer process increased slightly whereas the number of patients with advanced forms of the disease increased significantly (41.5%). The percentage of patients identified during routine check-ups was 28.0% (in 2008 it was 15.8%). Mortality in the first year from the time of diagnosis was reduced to 49.2% (in 2008 – 55.0%) remaining, at the same time, at very high numbers, which makes it impossible to characterize medical care for oncology patients as adequate for the time required. In the structure of total mortality, trachea, bronchus and lung tumors (20.7%) take the first place significantly exceeding the Russian level (17.3%). There was designated the quality of the service’s activity according to the confidence index of accounting for this category of patients, which in 2017 did not fall below 0.6 in any of the territories forming the Far Eastern Federal District. A great deal of work of primary health care institutions responsible for identifying malignant neoplasms in the initial stages of the process, unfortunately, has not led to the desired reduction in morbidity and mortality in the Far Eastern Federal District in the last decade. On the contrary, the level of intensive indicators of medical care for cancer patients in the region remains high, with an annual increase in mortality and the number of cases, especially among the female population

scholarly journals Epidemiological features of laryngeal cancer in the Far Eastern Federal District

2021 ◽  
pp. 32-41
Author(s):  
V. P. Gordienko ◽  
K. V. Yanushevsky ◽  
D. T. Ekonia
Keyword(s):  
Laryngeal Cancer ◽  
Total Mortality ◽  
Federal District ◽  
Morbidity And Mortality ◽  
Simultaneous Increase ◽  
Malignant Neoplasms ◽  
Female Population ◽  
The Past ◽  
Number Of Patients ◽  
Far Eastern

Aim. A scientific assessment of the main indicators of morbidity and mortality of the population from laryngeal cancer in the Far Eastern Federal District over the past ten years (2009-2019).Materials and methods. In the process of work, indicators of morbidity and mortality, reporting forms of statistical registration of oncological patients and regulatory documents of higher organizations, information on ten-year observations on the dynamics of changes in digital values of the investigated pathology were used.Results. The main data on morbidity and mortality of patients with laryngeal cancer are given in the Far Eastern Federal District, where 2019 new cases of malignant neoplasms were registered in 34152, which is 8.5% more than ten years ago. There were 2171 patients with laryngeal cancer under outpatient observation, i.e. 26.5% per 100.000 population in the region. In the structure of primary morbidity and total mortality among all departments of the respiratory system, laryngeal cancer ranked second after malignant neoplasms of the trachea, bronchi and lung. During the study period, the number of patients with advanced forms of the disease increased with a simultaneous decrease in the number of patients with stages I and II of the oncological process. Over the past ten years, the incidence of disease has increased more significantly in the female population. The percentage of actively identified patients during this time increased by several orders of magnitude, with a simultaneous increase in the index of the accumulation of populations of patients with laryngeal cancer. Morphological confirmation of the diagnosis was lower than the Russian average. The proportion of patients registered for five years or more did not reach the average republican values. Lethality in the first year since the diagnosis was established was characterized by dynamically decreasing digital values, despite the increase in the number of neglected cases, which can be explained by the high level of modern methods of treatment.Conclusion. Against the background of the increasing absolute number of patients with malignancies in the Far Eastern Federal District in 2019, there was a decrease in standardized indicators (world standard) of morbidity and mortality from laryngeal cancer in the male population, with an increase in the number of women who fell ill and died from this pathology.

scholarly journals The state of cancer care in Russia: lung cancer, patient survival (population study at the federal district level)

2021 ◽  
Vol 67 (4) ◽  
pp. 492-500
Author(s):  
Vakhtang Merabishvili ◽  
Iuliia Iurkova ◽  
Evgenii Levchenko ◽  
Aleksandr Shcherbakov ◽  
Nikolai Krotov
Keyword(s):  
Lung Cancer ◽  
Mortality Rate ◽  
Relative Survival ◽  
Federal District ◽  
Developed Countries ◽  
Morbidity And Mortality ◽  
Malignant Neoplasms ◽  
Male Population ◽  
Female Population ◽  
One Year

Lung cancer (LC) remains the main cause of morbidity and mortality in many economically developed countries of the world. In 2019, more than 60 thousand primary cases of LC and more than 50 thousand deaths from this cause were recorded in Russia. The registration reliability index remains high - 0.83, which indicates a significant underestimation of primary patients.At the same time, it should be noted that the standardized rates of morbidity and mortality from LC continue to decline. The most effective criterion for evaluating the activity of the oncological service is the indicator of the observed and relative survival of patients with malignant neoplasms (MNO). Such a possibility exists in many territories of Russia, but it is calculated only in selected territories working according to our programs, and first of all, in the newly created population cancer register of the Northwestern Federal District (NWFD) with a database (DB) of more than 1 million. 350 thousand observations.The results obtained can be fully extended to the whole of Russia, since the levels of standardized indicators of morbidity and mortality from LC in Russia and the NWFD of the Russian Federation are practically identical.The study showed that from 2000 to 2017, the median survival rate of patients with LC in the NWFD increased from 6.4 to 8.0 months, and the one-year mortality rate decreased from 65,2% to 60,8%.The change in indicators is extremely slow. Differences in the mortality rate (in standardized indicators) from LC between men and women differ in Russia by 7,1, in the NWFD of the RF - by 7.0.Mortality in men from LC in the first year of observation is 63.5% versus 52.5% among the female population, which is primarily due to the peculiarities of the industrial production process and bad habits that are more characteristic of the male population.

scholarly journals Analysis of the availability and direction of improvement of medical care for patients with malignant neoplasms in the Moscow region

2018 ◽  
Vol 5 (4) ◽  
pp. 106-117
Author(s):  
E. Yu. Ogneva ◽  
A. N. Gurov ◽  
M. V. Pirogov ◽  
E. V. Gameeva ◽  
O. Yu. Aleksandrova
Keyword(s):  
Medical Care ◽  
Cancer Patients ◽  
Russian Federation ◽  
Federal District ◽  
Moscow Region ◽  
High Tech ◽  
Malignant Neoplasms ◽  
Patients With Cancer ◽  
The Subject ◽  
The Russian Federation

Purpose. Carrying out medical and statistical analysis of morbidity and mortality of the population with malignant neoplasms, development of proposals for greater accessibility and areas of improvement of specialized including high-tech medical care (HTMC) for patients with cancer in the Moscow region.Materials and methods. The analysis of morbidity and mortality of the population of the Moscow region from malignant neoplasms and the organization of specialized, including high-tech, medical care to cancer patients on the basis of forms of Federal state statistical observations in relation to the three-level system of the organization of medical care to the population of the region with identification of organizational and financial problems.Results. The incidence of malignant neoplasms in the Moscow region in 2017 amounted to 364.9 per 100 thousand population, which is 1.0% below the level of 2016-365.9 per 100 thousand population and below the average for the Central Federal district and the Russian Federation. The mortality rate from neoplasms in the Moscow region decreased in 2017 to 174.7 cases per 100 thousand population, which is less than the average for the Central Federal district — 207.1 and the Russian Federation — 196.9 per 100 thousand population. At the same time, the volume of specialized medical care (including high — tech medical care) for malignant tumors, in a 24-hour hospital is more than twice the average Russian standard — 13% for SMC and 50% for HTMC. Exceeding the standard of medical care is mainly due to the HTMC 2, which is not planned in the subject of the Russian Federation and is usually in Federal clinics. The share of oncological medical care received outside the medical organizations of the MR is 16%, which exceeds the share of medical care in all other profiles received outside the Moscow region (12%). This situation contributes to the availability of cancer care to the population of the Moscow region.Conclusion. The performed work allowed to draw conclusions that in normative legal acts of Federal level it is necessary to define separately the standard of volumes of specialized, including hi-tech medical care, on the profile of Oncology. Large volumes of HTMC cannot be an unambiguous characteristic of the availability of medical care in General, since HTMC is medical care with the use of complex methods of diagnosis and treatment in clinically complex cases. Large volumes of HTMC can be a consequence of the complexity of clinical cases, but also a consequence of neglect of the disease due to the lack of diagnosis and treatment in the provision of primary health care (PHC) at the 1st level. In the Moscow region, there is a need to redistribute the volume of this medical care not only to cancer dispensaries, but also to other medical organizations. After that, there is a need for the distribution of patients, taking into account the morbidity in the territories, the place of residence of citizens, and taking into account the capabilities of medical organizations for the treatment of cancer patients (surgical treatment, chemotherapy, radiotherapy). Medical organizations of the subject of the Federation shall be ranked taking into account the applied technologies and opportunities of drug therapy. As a result, a clear routing of patients with cancer should be developed in the subject of the Russian Federation.

scholarly journals Анализ заболеваемости и смертности населения от злокачественных новообразований на территории Приморского края (за период 2015–2017 гг.)

2020 ◽  
pp. 74-78
Keyword(s):  
Comparative Analysis ◽  
Russian Federation ◽  
Federal District ◽  
Morbidity And Mortality ◽  
Malignant Neoplasms ◽  
Primorsky Krai ◽  
Analysis And Evaluation ◽  
The Russian Federation ◽  
Far Eastern

The analysis of morbidity and mortality in the Primorsky Krai from malignant neoplasms is presented in the article. A comparative analysis and evaluation of similar indicators in the Russian Federation and the Far Eastern Federal District was performed.

Эпидемиологические особенности рака предстательной железы в Дальневосточном федеральном округе

2020 ◽  
pp. 79-85
Keyword(s):  
Prostate Cancer ◽  
Far East ◽  
Federal District ◽  
Mortality Rates ◽  
Reproductive Organs ◽  
Morbidity And Mortality ◽  
Malignant Neoplasms ◽  
Male Population ◽  
The Far East ◽  
Number Of Patients

Background. Recent decades in the Far East Federal District have been characterized by a constant increase in the number of patients with oncological pathology, in the structure of which prostate tumors are the second largest cause of mortality in men. The goal of this study was a scientific assessment of the main rates of morbidity and mortality of prostate cancer in the male population in the Far East Federal District for the last ten years (2009–2018). Material and methods. During the study, the indicators of morbidity and mortality, reporting forms of statistical registration of oncological patients and regulatory documents of higher-level organizations, information on ten-year observations of the dynamics of changes in digital indicators of the investigated pathology were used. Results of the research. The main rates of morbidity and mortality of prostate cancer patients in the Far East Federal District are given, where 33,111 new cases of malignant neoplasms were registered in 2018, that is 24,6 % higher than ten years ago (20 191 people in 2009). In Russia, such increase was 21,6 % higher. 9 324 patients, i.e. 0,12 % population of the region, were under medical supervision. The number of patients with I-II stages of the disease (60,9 %) increased during the investigated period with simultaneous reduction of the number of patients with neglected forms (38,1 %) of the disease. Morbidity and mortality rates have been increasing steadily over the past 10 years. The percentage of actively identified patients has increased, as well as the year-end accumulation index. Morphological confirmation of the diagnosis (over 95 %) did not exceed the average republican indicators (95,9 %). The proportion of patients registered for 5 years or more was lower than averagely in Russia, but mortality rates improved in the first year from the time of the initial diagnosis (2009 – 17,3 %; 2018 – 10,1 %; Russian Federation – 7,8 %). As far as the localizations in the male reproductive organs, neglected prostate cancer remains at the highest level.

scholarly journals Incidence of pancreatic malignancies in the Russian Federation: a retrospective cohort trial

2021 ◽  
Vol 28 (3) ◽  
pp. 97-111
Author(s):  
V. E. Moiseenko ◽  
A. V. Pavlovsky ◽  
D. A. Granov ◽  
I. G. Kardanova ◽  
L. V. Kochorova ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Patients ◽  
Russian Federation ◽  
Morbidity And Mortality ◽  
Malignant Neoplasms ◽  
Female Population ◽  
Pancreatic Malignancy ◽  
Incidence And Mortality ◽  
Depth Analysis ◽  
Comparison Cohort

Background. Pancreatic malignancies pose a challenging medical and social problem. The assessment of oncology care requires an in-depth analysis of morbidity and lethality. At a relatively improved prevalence and lethality in other-locale malignancies, pancreatic cancer remains a disappointing situation. Medical statistics in pancreatic malignancy can be used for the specialty care prediction and implementation of measures to advance diagnostic algorithms and population screening.Objectives. An assessment of the pancreatic malignancy incidence and mortality in the adult population of Russian Federation over a six-year period.Methods. A retrospective descriptive cohort trial included statistical data on morbidity and mortality in pancreatic cancer patients (C 25.0-C 25.9) according to the ICD of 10th edition. A comparison cohort sampled patients with all-locale neoplasms (C00-C96) according to the ICD of 10th edition, excluding nosologies C25.0-C25.9. Information was sourced in the Federal Statistical Abstracts for the period of 2014-2019. Inclusion criteria: the study cohort included pancreatic cancer patients diagnosed at the age of 18 years on, and comparison cohort — malignancy patients diagnosed with at 18 years on. The main study indicator were the pancreatic cancer morbidity and mortality figures in Russia.Results. Pancreatic cancer was shown to co-increase main morbidity figures in 2014-2019 compared to malignant neoplasms of other localities. Other-locale malignancies decreased mortality over the study period, which was not the case with pancreatic cancer. The period exhibits more frequent morphologically verified diagnoses and higher population numbers registered with specialty dispensaries. Registered pancreatic cancer figures are significantly higher in the female population. The proportion of advanced pancreatic malignancies at primary diagnosis exceeds that of early stages.Conclusion. The findings expose a demand for improving the system of early pancreatic cancer detection via intensifying preventive measures to capture the patient’s predisposition and screening techniques for early disease diagnosis. An active outpatient surveillance is prerequisite to an effective population involvement in dispensary screening.

EPIDEMIOLOGY OF ESOPHAGEAL CANCER IN THE RUSSIAN EASTERN REGIONS

2021 ◽  
Vol 67 (2) ◽  
pp. 2-2
Author(s):  
V.P. Gordienko ◽  
◽  
A.A. Vakhnenko ◽  
Keyword(s):  
Esophageal Cancer ◽  
Total Mortality ◽  
Morbidity And Mortality ◽  
Simultaneous Increase ◽  
Malignant Neoplasms ◽  
Female Population ◽  
Number Of Patients ◽  
Study Results ◽  
Regions Of Russia

A constant increase in the number of patients with malignant neoplasms in Russia sets a task for the State to overcome the existing difficulties in improving major indicators of morbidity and mortality from esophageal cancer, taking into account individual territorial problems The purpose of the study was to evaluate major indicators of morbidity and mortality from esophageal cancer in the Eastern regions of Russia over the ten-year period (2009-2019). Material and methods. The study used indicators of morbidity and mortality, reporting forms of statistical registration of cancer patients and regulatory documents of higher-level organizations, information on ten-year observations on the dynamics in changes in digital values of the pathology under study. Results. The study presents data on morbidity and mortality from esophageal cancer among patients in the Far Eastern Federal District: 34152 new cancer cases were registered in 2019 which is 8.5% higher than ten years ago. 988 patients with esophageal cancer were under medical follow-up i.e. 12.0 per 100,000 population in the region. In the structure of incidence and total mortality among all parts of the gastrointestinal tract, esophageal cancer ranked second after malignant neoplasms of stomach. During the study period, the number of patients with advanced forms of the disease decreased (29.8%) with a parallel light increase in the number of patients with cancer stages I and II (33.3%). Over the past ten years, the morbidity increased more in the female population (2.01 о/оооо). The share of actively detected patients during this time increased multi-fold (15.4%), with a simultaneous increase in the number of patients with esophageal cancer (1.9). The number of morphologically confirmed cases was lower than the Russian average (91.6%). The share of patients registered for medical follow-up over five years did not reach the average republican values (37.0%). Deaths within the first year of diagnosis were characterized by dynamically decreasing digital values against the background of high indicators (55.3%, and 57.6% in the Russian Federation). Conclusion. Against the background of the increasing absolute number of patients with malignant neoplasms in the Eastern regions of Russia in 2019, standardized indicators (Standard population) of mortality from esophageal cancer in the male population increased with a rise in the number of women who developed and died from esophageal cancer.

CANCER OF THE LARYNX IN THE AMUR REGION OF FAR EASTERN FEDERAL DISTRICT

2016 ◽  
Vol 1 (60) ◽  
pp. 45-51
Author(s):  
Геращенко ◽  
Larisa Gerashchenko ◽  
Гордиенко ◽  
Viktor Gordienko ◽  
Колтыгина ◽  
...  
Keyword(s):  
Malignant Tumors ◽  
Federal District ◽  
Amur Region ◽  
First Year ◽  
Cancer Services ◽  
Number Of Patients ◽  
Growth Loss ◽  
Analysis Of Dynamics ◽  
Far Eastern

The article analyzes the main indicators of morbidity and mortality from cancer of the larynx in the period from 1998 to 2014 on the territory of the Amur region of Far Eastern Federal District. In the studied period of time, the incidence of malignant tumors of the larynx substantially decreased with the growth/loss in men of “rough indicators” by -11.89%, of standardized ones by -7.75%. In women, they were +98.31 and +77.77%, respectively. Mortality in contrast to the incidence throughout the years had a negative growth (loss) in absolute terms, “rude” and standardized indicators. The age and sex features of morbidity with larynx cancer were revealed; they show that the maximum number of cancer cases is in the age group of 50 years old and older. The multistage character of the process based on its prevalence was determined. The early stages (I-II) of laryngeal cancer were registered in 13.7% of patients. The quality of cancer services activity was studied by reliability index of accounting for this category of patients, which is usually lower than in other regions of the country (-0.45). The analysis of dynamics of mortality in the first year after diagnosis shows its reduction in cancer of the larynx by 11.0% over the period of 1998-2014. The number of patients who were registered five or more years ago decreased significantly. The estimation of primary care, which is not yet fully in line with current medicine, in the provision of specialized aid to cancer patients in the region was done.

Illness understanding of oncology patients in a community-based cancer institute.

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e21605-e21605
Author(s):  
Shanthi Sivendran ◽  
Sarah Jenkins ◽  
Sarah Svetec ◽  
Michael Horst ◽  
Kristina Braine Newport ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Advanced Cancer ◽  
Stage I ◽  
Cancer Stage ◽  
Stage At Diagnosis ◽  
Advanced Cancer Patients ◽  
Community Based ◽  
Oncology Patients ◽  
Remission Status ◽  
Number Of Patients

e21605 Background: Several studies have demonstrated patients have a poor understanding of prognosis, survival and effectiveness of chemotherapy, particularly in the setting of advanced cancer. This study examines oncology patients’ understanding of their illness based on accurate reporting of stage at diagnosis as well as knowledge of remission status. Methods: 208 cancer patients previously treated at our large community based cancer institute participated in The Consumer-Based Cancer Care Value Index (CCCVI) Field Survey. Electronic medical record (EMR) documentation of stage at diagnosis and remission status were compared to patients’ self-reported responses. Concordance of responses and variables influencing discordance were evaluated. Results: 51.0% of patients’ self-reported cancer stage matched the abstracted stage with the highest concordance in the advanced cancer patients (72%) versus stage I-III patients (36.4%-61.5%). Unexpectedly, discordance was lower among advanced cancer patients as compared to stage I-III patients (p = 0.0528) Those who were concordant for cancer stage at diagnosis were significantly more likely to be female (p = 0.001), under the age of 65 (p = 0.01), have an income greater than $60,000 (p = 0.03), and have more education (p = 0.02). 64.4% of patients’ self-reported remission status matched the abstracted status. Nearly 30% of patients were not sure about their status even when they were in remission. Conclusions: Our findings confirm that more than one quarter of patients with advanced cancer have poor illness understanding, as well as highlights that an even greater number of patients with early stage I-III cancers have poor illness understanding. These observations highlight the need to improve illness understanding for patients across the entire cancer continuum.

Sign in / Sign up

Export Citation Format

Share Document